Minerva Neurosciences Shares Dip 0.42% as Market Cap Hits $114 M in 2026
Minerva Neurosciences stock rises 0.42% as its biotech firm pursues new CNS therapies—track its 2026 market cap, price trends, and related stocks for investors.
- MINERVA NEUROSCIENCES INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
One minute to read